Biosergen publishes interim report for third quarter 2022
Wednesday, November 30, 2022: Biosergen AB (“Biosergen” or the “Company”) thereby publishes the interim report for the third quarter 2022. The interim report is available as an attached document and on the company website (www.biosergen.netSummary of the Interim Report for Q3 2022 2022 2021 2022 2021 2021TSEK July-Sep July-Sep Jan-Sep Jan-Sep Jan-Dec Other income 493 2.652 3.219 4.653 8.573Profit/loss -14.515 -6.404 -27.496 -24.202 -34.077beforedepreciation(EBITDA)Operating -14.515